Skip to main content
    • Aa
    • Aa

A retrospective, exploratory, secondary analysis of the association between antipsychotic use and mortality in elderly patients with delirium

  • M. Elie (a1), K. Boss (a1), M. G. Cole (a1), J. McCusker (a2), E. Belzile (a2) and A. Ciampi (a2)...

Background: Delirium, an acute altered level of cognition, is a frequent complication of medical illness in the elderly. Antipsychotic medications (APs) are often used to treat agitation and psychosis in delirium. The goal of this study is to compare mortality in delirious elderly medical inpatients treated with APs with those who did not receive APs.

Method: 326 elderly hospitalized patients were identified with delirium at an acute care community hospital. A nested case-control analysis was conducted on this cohort. Cases consisted of all patients who died in hospital within eight weeks of admission. Each case was matched for age and severity of illness to patients (controls) alive on the same day post-admission. Conditional logistic regression was used to assess the impact of exposure to AP on mortality. Covariates used for adjustment were the Charlson comorbidity score and the acute physiology score. Odds ratio (OR) and 95% confidence intervals were calculated from the regression coefficients.

Results: 111 patients received an AP. A total of 62 patients died, 16 of whom were exposed to an AP. The OR of association between AP use and death was 1.53 (95% C.I, 0.83–2.80) in univariate and 1.61 (95% C.I, 0.88–2.96) in multivariate analysis.

Conclusion: In elderly medical inpatients with delirium, administration of APs was not associated with a statistically significant increased risk of mortality. Larger studies are needed to clarify the safety of AP medication in elderly patients with delirium.

Corresponding author
Correspondence should be addressed to: M. Elie, M.D., FRCP(C), Department of Psychiatry, St-Mary's Hospital Center, 3830 Lacombe Avenue, Montreal, Quebec, H3T 1M5, Canada. Phone: +1 514 345 3511 ext. 5132; Fax: +1 514 734 2609. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

M. Carnes , T. Howell , M. Rosenberg , J. Francis , C. Hildebrand and J. Knuppel (2003). Physicians vary in approaches to the clinical management of delirium. Journal of the American Geriatrics Society, 51, 234239.

M. E. Charlson , F. L. Sax , R. MacKenzie , S. D. Fields , R. L. Braham and R. G. Douglas (1986). Assessing illness severity: does clinical judgment work?. Journal of Chronic Diseases, 39, 439452.

M. G. Cole (2004). Delirium in elderly patients. American Journal of Geriatric Psychiatry, 12, 721.

S. Gill (2007). Antipsychotic drug use and mortality in older adults with dementia. Annals of Internal Medicine, 146, 775786.

S. K. Inouye (2006). Delirium in older persons. New England Journal of Medicine, 354, 11571165.

L. Kryzhanovskaya (2006). A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia. Journal of Clinical Psychiatry, 67, 933945.

J. Lubin and M. Gail (1984). Biased selection of controls for case-control analyses of cohort studies. Biometrics, 40, 6375.

E. Pfeiffer (1975). A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society, 23, 433441.

P. Rochon (2008). Antipsychotic therapy and short-term serious events in older adults with dementia. Annals of Internal Medicine, 168, 10901096.

J. Ryan (2001). Optimizing management of delirium: placebo controlled trials of pharmacological treatment are needed. BMJ, 322, 1602.

S. Schneeweiss , S. Setoguchi , A. Brookbort , C. Darmuth and P. Wang (2007). Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Canadian Medical Association Journal, 176, 627632.

L. S. Schneider , K. S. Dagerman and P. Insel (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA, 294, 19341943.

P. Wang (2005). Risk of death in elderly users of conventional vs atypical antipsychotic medications. The New England Journal of Medicine, 353, 23352341.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 3
Total number of PDF views: 19 *
Loading metrics...

Abstract views

Total abstract views: 95 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 29th May 2017. This data will be updated every 24 hours.